JP Morgan Chase’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
JP Morgan Chase's ADRX Position: Q3 2026 in Review
JP Morgan Chase opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 88 shares worth $1.82K. The stake represents ﹤0.01% of the portfolio and ranks #7486 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- JP Morgan Chase held 88 shares of ADARx Pharmaceuticals worth $1.82K as of Q3 2026.
- ADARx Pharmaceuticals was a new JP Morgan Chase position in Q3 2026.
- ADARx Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7486 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.